Live feed
Filing
SC 13G
SC 13G0000315066-20-001679·Kalaris Therapeutics, Inc.
Schedule 13G ownership disclosure
ALLOVIR INC
Security class unavailable · CUSIP: 019818103
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.1210%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-20-001679
- Form type
- SC 13G
- Filer
- Kalaris Therapeutics, Inc.
- CIK
- CIK 1754068
- Filed
- Aug 10, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership